Market closed

Conmed/$CNMD

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About Conmed

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.

Ticker

$CNMD

Sector

Health Care

Trading on

NYSE

Industry

Health Care Equipment & Supplies

Headquarters

Largo, United States

Employees

4,000

Website

www.conmed.com

Conmed Metrics

BasicAdvanced

$2.1B

16.47 $4.22

1.46 $0.80

1.15%

Price and volume

Market cap

$2.1B

Beta

1.46

52-week high

$111.10

52-week low

$61.05

Average daily volume

373K

Dividend rate

$0.80

Financial strength

Current ratio

2.271

Quick ratio

0.955

Long term debt to equity

100.772

Total debt to equity

100.848

Dividend payout ratio (TTM)

18.69%

Interest coverage (TTM)

3.89%

Management effectiveness

Return on assets (TTM)

3.98%

Return on equity (TTM)

15.24%

Valuation

Price to earnings (TTM)

16.465

Price to revenue (TTM)

1.662

Price to book

2.3

Price to tangible book (TTM)

-4.3

Price to free cash flow (TTM)

12.886

Dividend yield (TTM)

1.15%

Forward dividend yield

1.15%

Growth

Revenue change (TTM)

10.23%

Earnings per share change (TTM)

127.40%

3-year revenue growth (CAGR)

9.19%

3-year earnings per share growth (CAGR)

29.69%

What the Analysts think about Conmed

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Conmed stock.

Conmed Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

Conmed Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Conmed News

AllArticlesVideos

CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025

Business Wire·1 week ago

CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference

Business Wire·2 months ago

CONMED Corporation (CNMD) Q3 2024 Earnings Call Transcript

Seeking Alpha·3 months ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CNMD

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Conmed stock?

Conmed (CNMD) has a market cap of $2.1B as of January 15, 2025.

What is the P/E ratio for Conmed stock?

The price to earnings (P/E) ratio for Conmed (CNMD) stock is 16.47 as of January 15, 2025.

Does Conmed stock pay dividends?

Yes, the Conmed (CNMD) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is $0.8 and the yield is 1.15%. Conmed has a payout ratio of 18.69% on a trailing twelve-month basis.

When is the next Conmed dividend payment date?

The next Conmed (CNMD) dividend payment date is unconfirmed.

What is the beta indicator for Conmed?

Conmed (CNMD) has a beta rating of 1.46. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.